Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone

Eur J Med Chem. 2016 Jun 10:115:132-40. doi: 10.1016/j.ejmech.2016.03.014. Epub 2016 Mar 5.

Abstract

A range of close analogues of deferiprone have been synthesised. The group includes mono-, di- and tri-methyl-3-hydroxy-4(1H)-pyridones. These compounds were found to possess similar pFe(3+) values to that of deferiprone, with the exception of the 2.5-dimethylated derivatives. Surprisingly the NH-containing hydroxy-4(1H)-pyridones were found to be marginally more lipophilic than the corresponding N-Me containing analogues. This same group are also metabolised less efficiently by Phase 1 hydroxylating enzymes than the corresponding N-Me analogues. As result of this study, three compounds have been identified for further investigation centred on neutropenia and agranulocytosis.

Keywords: HPO; Iron(III)chelator; Orally active.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Deferiprone
  • Humans
  • Hydrogen-Ion Concentration
  • Iron Chelating Agents / administration & dosage
  • Iron Chelating Agents / chemistry*
  • Iron Chelating Agents / metabolism
  • Microsomes, Liver / metabolism
  • Pyridones / administration & dosage
  • Pyridones / chemistry*
  • Pyridones / metabolism

Substances

  • 3-hydroxy-4(1H)-pyridone
  • Iron Chelating Agents
  • Pyridones
  • Deferiprone